Lipophilicity of amyloid β-peptide 12-28 and 25-35 to unravel their ability to promote hydrophobic and electrostatic interactions

International Journal of Pharmaceutics
G ErmondiG Caron

Abstract

The growing interest for peptide therapeutics calls for new strategies to determine the physico-chemical properties responsible for the interactions of peptides with the environment. This study reports about the lipophilicity of two fragments of the amyloid β-peptide, Aβ 25-35 and Aβ 12-28. Firstly, computational studies showed the limits of log D(7.4)oct in describing the lipophilicity of medium-sized peptides. Chromatographic lipophilicity indexes (expressed as log k', the logarithm of the retention factor) were then measured in three different systems to highlight the different skills of Aβ 25-35 and Aβ 12-28 in giving interactions with polar and apolar environments. CD studies were also performed to validate chromatographic experimental conditions. Results show that Aβ 12-28 has a larger skill in promoting hydrophobic and electrostatic interactions than Aβ 25-35. This finding proposes a strategy to determine the lipophilicity of peptides for drug discovery purposes but also gives insights in unraveling the debate about the aminoacidic region of Aβ responsible for its neurotoxicity.

References

Mar 22, 2003·Biochimica Et Biophysica Acta·W Gibson WoodWalter E Müller
Nov 25, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Salwa K Poole, Colin F Poole
Jan 6, 2004·Journal of Neuroscience Research·Ruitian LiuMichael R Sierks
Mar 3, 2004·Medicinal Research Reviews·Georgette Plemper van BalenBernard Testa
Jun 13, 2006·Biophysical Journal·Guanghong Wei, Joan-Emma Shea
Jan 1, 2008·Journal of the American Chemical Society·Matthias Meier, Joachim Seelig
May 22, 2009·Journal of Neurochemistry·John Hardy
Sep 1, 2011·Analytical and Bioanalytical Chemistry·Bogusław Buszewski, Sylwia Noga
Aug 26, 2014·Frontiers in Chemistry·Laszlo Otvos, John D Wade
Dec 3, 2014·Drug Discovery Today·Keld Fosgerau, Torsten Hoffmann
Jan 13, 2015·Journal of Computer-aided Molecular Design·Alessia ViscontiRoberto Esposito

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.